
Bioorganic and Medicinal Chemistry Letters p. 1519 - 1524 (1997)
Update date:2022-09-26
Topics:
Kohno, Yasushi
Awano, Katsuya
Miyashita, Mitsutomo
Ishizaki, Takayoshi
Kuriyama, Kazuhiko
Sakoe, Yasuhiko
Kudoh, Shinji
Saito, Koji
Kojima, Eisuke
A study of the structural optimization of tetrahydroquinoline-6-acetic acid and the development of a novel DMARD with prompt action are detailed. (S)-(+)-8-Chloro-1,2,3,4-tetrahydro-2-trifluoromethyl-6- quinolineacetic acid (IRA-378) exhibits the effect against both acute and chronic inflammations. It also has suppressive effects of bone destruction in adjuvant arthritis and Ca release from bones in vitro.
View MoreJiangXi Keyuan Biopharma Co., LTD.
Contact:+86-563-6833666
Address:Guangde Fine Chemical Zone, Anhui Province, China
Xian Changyue Biological Technology Co., Ltd.
website:https://www.xachangyue.com/
Contact:+86-029-88211911
Address:Keji Road NO.70
Zhengzhou Institute of Chiral Pharmer Research Co., Ltd.
Contact:86-371-55219111
Address:15 Floor, 2 Building, Central China Technovalley, Zhongyuan West Road
Contact:0086 371 65711996
Address:Jalan 4/3, Kawasan Perindustrian Serendah, 48000 Rawang,
Hangzhou Eastbiopharm Co.,Ltd.
Contact:+86-571-88931780
Address:Hangzhou,China
Doi:10.1021/jo00072a019
(1993)Doi:10.1248/cpb.41.772
(1993)Doi:10.1021/ol403133b
(2014)Doi:10.1021/jo00071a025
(1993)Doi:10.1021/ol403364k
(2014)Doi:10.1039/c3ob42275e
(2014)